神经母细胞瘤中的抗体结合物:精密医学的前进一步
Jihane Balla1, Carlotta Siddi1, Maria Scherma1
1Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
Frontiers in oncology
|March 25, 2025
概括
抗体结合剂为高风险神经母细胞瘤 (NB) 提供向治疗,这是儿童癌症. 这些先进的治疗方法,包括抗体-药物合物和放射性免疫疗法,旨在通过将药物直接输送到瘤细胞来改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 生物技术是生物技术.
背景情况:
- 神经母细胞瘤 (NB) 是一种高风险的儿科癌症,经常复发,对标准治疗有抗性.
- 对于NB来说,急需新的,有针对性的治疗策略.
- 在NB细胞上的表面抗原为向治疗提供了机会.
研究的目的:
- 审查抗体结合剂在治疗神经母细胞瘤方面的进展和挑战.
- 要突出抗体-药物合物 (ADCs),免疫毒素 (ITs),放射性免疫疗法 (RIT) 和抗体-合物 (AFCs) 的潜力.
- 讨论未来的研究方向,以改善NB治疗结果.
主要方法:
- 对抗体结合技术的审查,包括ADC,IT,AFC和RIT.
- 分析它们在向神经母细胞瘤表面抗原中的应用.
- 讨论诸如有效载荷传递,非目标效应和瘤异质性等挑战.
主要成果:
- 抗体结合物使细胞毒剂或诊断工具能够精确地传递到瘤细胞.
- ADC,IT和RIT提供精密疗法,降低了全身毒性.
- AFC对于诊断和表征恶性组织非常有价值.
结论:
- 抗体结合体代表了神经母细胞瘤精密疗法的有希望的类别.
- 解决诸如瘤异质性和非标效应等挑战对于临床成功至关重要.
- 将这些技术整合到多模式治疗方案中,对于改善儿科NB患者的治疗结果至关重要.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.0K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K